IVD Raw Materials Market Outlook Signals Expansion To $43.76 Billion Through 2030

The in vitro diagnostics (IVD) raw materials sector is poised for impressive expansion over the coming years, driven by significant advancements and rising healthcare demands. Understanding the market dynamics, key industry players, and emerging trends provides valuable insight into how this critical segment is evolving to meet global diagnostic needs.

Projected Market Size and Growth Trajectory of the IVD Raw Materials Market
The IVD raw materials market is anticipated to experience robust growth, reaching a valuation of $43.76 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 9.8%. The rising incidence of chronic and infectious diseases plays a substantial role in fueling this growth. Additionally, increasing investments in precision diagnostics, the surge in point-of-care testing, the expansion of biopharmaceutical research and development, and a growing demand for tailored raw materials are significant contributors to the market's upward trajectory. Key trends shaping this growth include a higher demand for purer diagnostic reagents, widespread adoption of recombinant antibodies and proteins, increased use of molecular diagnostics raw materials, a stronger emphasis on quality and consistency between batches, and efforts to diversify supply chains for essential IVD inputs.

The ivd raw materials market size has grown strongly in recent years. It will grow from $27.47 billion in 2025 to $30.16 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to growth in clinical diagnostic testing volumes, increasing adoption of immunoassays, expansion of molecular diagnostics, rising demand for early disease detection, established use of enzymes and antibodies in ivd kits.

Download a free sample of the ivd raw materials market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24270&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Principal Participants in the IVD Raw Materials Industry
Several prominent companies dominate the IVD raw materials market landscape. Notable leaders include Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., LGC Limited, Neogen Corporation, MP Biomedicals, CUSABIO Technology, Fujirebio, Fapon Biotech, ABclonal Technology, Creative Diagnostics, AIVD Biotech Inc., OPERON, Beijing Diagreat Biotechnology Co. Ltd., Biosynth, Aalto Bio Reagents, Angstrom Biotech, Eximio Biotech, Glentham Life Sciences Limited, OYC Americas Inc., NOVA Biologics Inc., Sino Biological Inc., ACROBiosystems, and ProSpec-Tany TechnoGene Ltd.

Strengthening Supply Chains Through Strategic Acquisitions in the IVD Market
In June 2025, Fujirebio Holdings, Inc., a Japan-based leader in in vitro diagnostics and life sciences technology, completed the acquisition of Plasma Services Group, Inc. Although financial terms were undisclosed, this move was designed to bolster Fujirebio's supply chain capabilities and reinforce its position as a reliable supplier of rare and critical biological raw materials worldwide. Plasma Services Group, headquartered in the United States, specializes in collecting, screening, and supplying high-quality biological specimens like sera and other samples essential for control reagents and calibrators across various diseases. Their operations are based at an FDA-registered and ISO-certified facility in Moorestown, New Jersey.

View the full ivd raw materials market report:
https://www.thebusinessresearchcompany.com/report/ivd-raw-materials-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Innovations and Future Directions in the IVD Raw Materials Market
Leading companies in the IVD raw materials field are increasingly investing in advanced manufacturing solutions to enhance regional diagnostic infrastructure and promote healthcare self-reliance. Specifically, IVD manufacturing facilities are specialized plants where diagnostic devices and related equipment are developed, produced, and tested to meet rigorous quality and regulatory standards. A notable development occurred in January 2024 when Colexa Biosensor Limited, a Nigerian health tech firm, partnered with Codix Pharma Limited, a pharmaceutical manufacturer in Nigeria, to establish Sub-Saharan Africa's first IVD manufacturing facility in Lagos. This facility produces the onpoint blood glucose meter and strips, addressing rising diabetes rates and improving diagnostic access in the region. With an initial annual production capacity of 3.6 million packs and potential expansion to 10.8 million, the facility primarily serves the needs of West Africa.

Segmentation Overview of the Global IVD Raw Materials Market
The IVD raw materials market is categorized based on several factors:
1) Product Types: Antibodies, Antigens, Enzymes, Proteins, and Biological Buffers.
2) Technology Types: Molecular Diagnostics, Clinical Chemistry, and Immunochemistry.
3) End Users: Pharmaceutical and Biotechnology Companies, and Contract Research Organizations.

Further breakdown includes:
- Antibodies segmented into Monoclonal, Polyclonal, and Recombinant types.
- Antigens divided into Recombinant, Native, and Synthetic categories.
- Enzymes classified as Polymerases, Reverse Transcriptases, and Oxidases.
- Proteins sorted into Carrier Proteins, Blocking Proteins, and Recombinant Proteins.
- Biological Buffers including Tris Buffers, HEPES Buffers, and Phosphate Buffers.

This detailed categorization helps paint a comprehensive picture of the market's structure and supports strategic decision-making within the IVD raw materials industry.

Our 2026 market reports now include enhanced strategic insights through:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.